Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 119.05 M126.6 M126.48 M130.29 M135.76 M 519.13 M Research & development ————— — Operating income 27.62 M-52.51 M46.64 M31.23 M33.59 M 58.95 M Non-Operating Income, Total -709 K-653 K-270 K-277 K-23 K -1.22 M Interest expense, net of interest capitalized 9.54 M12.78 M10.94 M10.78 M9.88 M 44.38 M Non-Operating Income, excl. Interest Expenses -1.37 M-1.41 M-849 K-880 K-646 K -3.78 M Unusual income/expense 660 K752 K579 K603 K623 K 2.56 M Pretax income 20.46 M-61.09 M39.75 M23.09 M26.89 M 28.63 M Equity in earnings 3.09 M4.85 M4.32 M2.92 M3.2 M 15.29 M Taxes 7.54 M5.47 M9.27 M2.33 M7.14 M 24.21 M Non-controlling/minority interest -5 00017 K17 K58 K73 K 165 K After tax other income/expense ————— — Net income before discontinued operations 12.92 M-66.58 M30.47 M20.7 M19.67 M 4.26 M Discontinued operations ————— — Net income 12.92 M-66.58 M30.47 M20.7 M19.67 M 4.26 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 12.9 M-66.5 M30.44 M20.69 M19.66 M 4.29 M Basic earnings per share (Basic EPS) 0.73-3.781.751.161.13 0.26 Diluted earnings per share (Diluted EPS) 0.73-3.781.751.161.13 0.26 Average basic shares outstanding 17.64 M17.57 M17.36 M17.47 M17.33 M — Diluted shares outstanding 17.67 M17.59 M17.42 M17.47 M17.41 M — EBITDA -74.38 M-189.03 M-87.91 M-118.32 M-104.27 M -499.54 M EBIT -112.72 M-205.74 M-104.92 M-135.58 M-122 M -568.23 M Cost of revenue 281.65 M311.68 M312.98 M302.95 M303.74 M 1.23 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 14.85 M16.7 M17.02 M17.25 M17.73 M 68.7 M